1. Home
  2. MESO vs USAS Comparison

MESO vs USAS Comparison

Compare MESO & USAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mesoblast Limited

MESO

Mesoblast Limited

HOLD

Current Price

$14.27

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Logo Americas Gold and Silver Corporation no par value

USAS

Americas Gold and Silver Corporation no par value

HOLD

Current Price

$4.85

Market Cap

1.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
MESO
USAS
Founded
2004
1998
Country
Australia
Canada
Employees
81
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Metal Mining
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
MESO
USAS
Price
$14.27
$4.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
N/A
$6.50
AVG Volume (30 Days)
175.9K
4.0M
Earning Date
02-26-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$629.74
$174.68
Revenue Next Year
$30.65
$53.17
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.32
$0.85
52 Week High
$21.50
$10.50

Technical Indicators

Market Signals
Indicator
MESO
USAS
Relative Strength Index (RSI) 49.97 43.25
Support Level $13.91 $4.60
Resistance Level $16.06 $5.12
Average True Range (ATR) 0.40 0.34
MACD -0.01 -0.01
Stochastic Oscillator 47.08 24.23

Price Performance

Historical Comparison
MESO
USAS

About MESO Mesoblast Limited

Mesoblast Ltd is a commercial-stage biotechnology company and a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The company's product candidates include: Ryoncil (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease, as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of an adult stem cell technology platform for commercialization.

About USAS Americas Gold and Silver Corporation no par value

Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets, which are also its reporting segments, are the Cosala operations, the Galena Complex, and Relief Canyon. It also holds interests in the San Felipe Development Project located in Sonora, Mexico. The Cosala operations segment, which derives maximum revenue, operates in Mexico, while the Galena Complex and Relief Canyon segments operate in the United States.

Share on Social Networks: